GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $640,000 | -7.0% | 14,700 | -7.0% | 0.01% | 0.0% |
Q1 2022 | $688,000 | -1.6% | 15,800 | -0.3% | 0.01% | +25.0% |
Q4 2021 | $699,000 | -41.8% | 15,850 | -49.5% | 0.00% | -50.0% |
Q3 2021 | $1,200,000 | -43.5% | 31,400 | -41.1% | 0.01% | -42.9% |
Q2 2021 | $2,124,000 | +24.0% | 53,350 | +11.1% | 0.01% | +27.3% |
Q1 2021 | $1,713,000 | -3.0% | 48,000 | 0.0% | 0.01% | -15.4% |
Q4 2020 | $1,766,000 | -7.6% | 48,000 | -5.5% | 0.01% | -13.3% |
Q3 2020 | $1,911,000 | -11.1% | 50,775 | -3.7% | 0.02% | -16.7% |
Q2 2020 | $2,150,000 | +6.2% | 52,700 | -1.4% | 0.02% | 0.0% |
Q1 2020 | $2,025,000 | -0.2% | 53,450 | +23.7% | 0.02% | +38.5% |
Q4 2019 | $2,030,000 | +301.2% | 43,200 | +264.6% | 0.01% | +333.3% |
Q3 2019 | $506,000 | -14.8% | 11,850 | -20.2% | 0.00% | -25.0% |
Q2 2019 | $594,000 | +5.3% | 14,850 | +10.0% | 0.00% | 0.0% |
Q1 2019 | $564,000 | +34.3% | 13,500 | +22.7% | 0.00% | +33.3% |
Q4 2018 | $420,000 | -19.5% | 11,000 | -15.4% | 0.00% | 0.0% |
Q3 2018 | $522,000 | -0.4% | 13,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $524,000 | +3.1% | 13,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $508,000 | +10.2% | 13,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $461,000 | -12.7% | 13,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $528,000 | -5.9% | 13,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $561,000 | +2.4% | 13,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $548,000 | +9.4% | 13,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $501,000 | -10.7% | 13,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $561,000 | -8.0% | 13,000 | -7.6% | 0.00% | -25.0% |
Q2 2016 | $610,000 | +6.8% | 14,076 | 0.0% | 0.00% | +33.3% |
Q1 2016 | $571,000 | +0.5% | 14,076 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $568,000 | +5.0% | 14,076 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $541,000 | -7.7% | 14,076 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $586,000 | -9.8% | 14,076 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $650,000 | +8.0% | 14,076 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $602,000 | -7.0% | 14,076 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $647,000 | -14.1% | 14,076 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $753,000 | +0.1% | 14,076 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $752,000 | 0.0% | 14,076 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $752,000 | +6.5% | 14,076 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $706,000 | +0.4% | 14,076 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $703,000 | – | 14,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |